[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Global Adrenoleukodystrophy Drugs Sales Market Report 2017

December 2017 | 103 pages | ID: G99CB09FA9CEN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the global Adrenoleukodystrophy Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Adrenoleukodystrophy Drugs for these regions, from 2012 to 2022 (forecast), covering
  • United States
  • China
  • Europe
  • Japan
  • Southeast Asia
  • India
Global Adrenoleukodystrophy Drugs market competition by top manufacturers/players, with Adrenoleukodystrophy Drugs sales volume, Price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Applied Genetic Technologies Corp
  • Bluebird Bio Inc
  • MedDay SA
  • Minoryx Therapeutics sl
  • Pfizer Inc
  • ReceptoPharm Inc
  • SOM Biotech SL
  • Viking Therapeutics Inc
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Biotin
  • DRX-065
  • DUOC-01
  • Lenti-D
  • MIN-102
  • OP-101
  • Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Children
  • Adult
If you have any special requirements, please let us know and we will offer you the report as you want.
Global Adrenoleukodystrophy Drugs Sales Market Report 2017

1 ADRENOLEUKODYSTROPHY DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Adrenoleukodystrophy Drugs
1.2 Classification of Adrenoleukodystrophy Drugs by Product Category
  1.2.1 Global Adrenoleukodystrophy Drugs Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 Global Adrenoleukodystrophy Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Biotin
  1.2.4 DRX-065
  1.2.5 DUOC-01
  1.2.6 Lenti-D
  1.2.7 MIN-102
  1.2.8 OP-101
  1.2.9 Others
1.3 Global Adrenoleukodystrophy Drugs Market by Application/End Users
  1.3.1 Global Adrenoleukodystrophy Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022)
  1.3.2 Children
  1.3.3 Adult
1.4 Global Adrenoleukodystrophy Drugs Market by Region
  1.4.1 Global Adrenoleukodystrophy Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 United States Adrenoleukodystrophy Drugs Status and Prospect (2012-2022)
  1.4.3 China Adrenoleukodystrophy Drugs Status and Prospect (2012-2022)
  1.4.4 Europe Adrenoleukodystrophy Drugs Status and Prospect (2012-2022)
  1.4.5 Japan Adrenoleukodystrophy Drugs Status and Prospect (2012-2022)
  1.4.6 Southeast Asia Adrenoleukodystrophy Drugs Status and Prospect (2012-2022)
  1.4.7 India Adrenoleukodystrophy Drugs Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Adrenoleukodystrophy Drugs (2012-2022)
  1.5.1 Global Adrenoleukodystrophy Drugs Sales and Growth Rate (2012-2022)
  1.5.2 Global Adrenoleukodystrophy Drugs Revenue and Growth Rate (2012-2022)

2 GLOBAL ADRENOLEUKODYSTROPHY DRUGS COMPETITION BY PLAYERS/SUPPLIERS, TYPE AND APPLICATION

2.1 Global Adrenoleukodystrophy Drugs Market Competition by Players/Suppliers
  2.1.1 Global Adrenoleukodystrophy Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Global Adrenoleukodystrophy Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Adrenoleukodystrophy Drugs (Volume and Value) by Type
  2.2.1 Global Adrenoleukodystrophy Drugs Sales and Market Share by Type (2012-2017)
  2.2.2 Global Adrenoleukodystrophy Drugs Revenue and Market Share by Type (2012-2017)
2.3 Global Adrenoleukodystrophy Drugs (Volume and Value) by Region
  2.3.1 Global Adrenoleukodystrophy Drugs Sales and Market Share by Region (2012-2017)
  2.3.2 Global Adrenoleukodystrophy Drugs Revenue and Market Share by Region (2012-2017)
2.4 Global Adrenoleukodystrophy Drugs (Volume) by Application

3 UNITED STATES ADRENOLEUKODYSTROPHY DRUGS (VOLUME, VALUE AND SALES PRICE)

3.1 United States Adrenoleukodystrophy Drugs Sales and Value (2012-2017)
  3.1.1 United States Adrenoleukodystrophy Drugs Sales and Growth Rate (2012-2017)
  3.1.2 United States Adrenoleukodystrophy Drugs Revenue and Growth Rate (2012-2017)
  3.1.3 United States Adrenoleukodystrophy Drugs Sales Price Trend (2012-2017)
3.2 United States Adrenoleukodystrophy Drugs Sales Volume and Market Share by Players
3.3 United States Adrenoleukodystrophy Drugs Sales Volume and Market Share by Type
3.4 United States Adrenoleukodystrophy Drugs Sales Volume and Market Share by Application

4 CHINA ADRENOLEUKODYSTROPHY DRUGS (VOLUME, VALUE AND SALES PRICE)

4.1 China Adrenoleukodystrophy Drugs Sales and Value (2012-2017)
  4.1.1 China Adrenoleukodystrophy Drugs Sales and Growth Rate (2012-2017)
  4.1.2 China Adrenoleukodystrophy Drugs Revenue and Growth Rate (2012-2017)
  4.1.3 China Adrenoleukodystrophy Drugs Sales Price Trend (2012-2017)
4.2 China Adrenoleukodystrophy Drugs Sales Volume and Market Share by Players
4.3 China Adrenoleukodystrophy Drugs Sales Volume and Market Share by Type
4.4 China Adrenoleukodystrophy Drugs Sales Volume and Market Share by Application

5 EUROPE ADRENOLEUKODYSTROPHY DRUGS (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Adrenoleukodystrophy Drugs Sales and Value (2012-2017)
  5.1.1 Europe Adrenoleukodystrophy Drugs Sales and Growth Rate (2012-2017)
  5.1.2 Europe Adrenoleukodystrophy Drugs Revenue and Growth Rate (2012-2017)
  5.1.3 Europe Adrenoleukodystrophy Drugs Sales Price Trend (2012-2017)
5.2 Europe Adrenoleukodystrophy Drugs Sales Volume and Market Share by Players
5.3 Europe Adrenoleukodystrophy Drugs Sales Volume and Market Share by Type
5.4 Europe Adrenoleukodystrophy Drugs Sales Volume and Market Share by Application

6 JAPAN ADRENOLEUKODYSTROPHY DRUGS (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Adrenoleukodystrophy Drugs Sales and Value (2012-2017)
  6.1.1 Japan Adrenoleukodystrophy Drugs Sales and Growth Rate (2012-2017)
  6.1.2 Japan Adrenoleukodystrophy Drugs Revenue and Growth Rate (2012-2017)
  6.1.3 Japan Adrenoleukodystrophy Drugs Sales Price Trend (2012-2017)
6.2 Japan Adrenoleukodystrophy Drugs Sales Volume and Market Share by Players
6.3 Japan Adrenoleukodystrophy Drugs Sales Volume and Market Share by Type
6.4 Japan Adrenoleukodystrophy Drugs Sales Volume and Market Share by Application

7 SOUTHEAST ASIA ADRENOLEUKODYSTROPHY DRUGS (VOLUME, VALUE AND SALES PRICE)

7.1 Southeast Asia Adrenoleukodystrophy Drugs Sales and Value (2012-2017)
  7.1.1 Southeast Asia Adrenoleukodystrophy Drugs Sales and Growth Rate (2012-2017)
  7.1.2 Southeast Asia Adrenoleukodystrophy Drugs Revenue and Growth Rate (2012-2017)
  7.1.3 Southeast Asia Adrenoleukodystrophy Drugs Sales Price Trend (2012-2017)
7.2 Southeast Asia Adrenoleukodystrophy Drugs Sales Volume and Market Share by Players
7.3 Southeast Asia Adrenoleukodystrophy Drugs Sales Volume and Market Share by Type
7.4 Southeast Asia Adrenoleukodystrophy Drugs Sales Volume and Market Share by Application

8 INDIA ADRENOLEUKODYSTROPHY DRUGS (VOLUME, VALUE AND SALES PRICE)

8.1 India Adrenoleukodystrophy Drugs Sales and Value (2012-2017)
  8.1.1 India Adrenoleukodystrophy Drugs Sales and Growth Rate (2012-2017)
  8.1.2 India Adrenoleukodystrophy Drugs Revenue and Growth Rate (2012-2017)
  8.1.3 India Adrenoleukodystrophy Drugs Sales Price Trend (2012-2017)
8.2 India Adrenoleukodystrophy Drugs Sales Volume and Market Share by Players
8.3 India Adrenoleukodystrophy Drugs Sales Volume and Market Share by Type
8.4 India Adrenoleukodystrophy Drugs Sales Volume and Market Share by Application

9 GLOBAL ADRENOLEUKODYSTROPHY DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

9.1 Applied Genetic Technologies Corp
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Adrenoleukodystrophy Drugs Product Category, Application and Specification
    9.1.2.1 Product A
    9.1.2.2 Product B
  9.1.3 Applied Genetic Technologies Corp Adrenoleukodystrophy Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.1.4 Main Business/Business Overview
9.2 Bluebird Bio Inc
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Adrenoleukodystrophy Drugs Product Category, Application and Specification
    9.2.2.1 Product A
    9.2.2.2 Product B
  9.2.3 Bluebird Bio Inc Adrenoleukodystrophy Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.2.4 Main Business/Business Overview
9.3 MedDay SA
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Adrenoleukodystrophy Drugs Product Category, Application and Specification
    9.3.2.1 Product A
    9.3.2.2 Product B
  9.3.3 MedDay SA Adrenoleukodystrophy Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.3.4 Main Business/Business Overview
9.4 Minoryx Therapeutics sl
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Adrenoleukodystrophy Drugs Product Category, Application and Specification
    9.4.2.1 Product A
    9.4.2.2 Product B
  9.4.3 Minoryx Therapeutics sl Adrenoleukodystrophy Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.4.4 Main Business/Business Overview
9.5 Pfizer Inc
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Adrenoleukodystrophy Drugs Product Category, Application and Specification
    9.5.2.1 Product A
    9.5.2.2 Product B
  9.5.3 Pfizer Inc Adrenoleukodystrophy Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.5.4 Main Business/Business Overview
9.6 ReceptoPharm Inc
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Adrenoleukodystrophy Drugs Product Category, Application and Specification
    9.6.2.1 Product A
    9.6.2.2 Product B
  9.6.3 ReceptoPharm Inc Adrenoleukodystrophy Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.6.4 Main Business/Business Overview
9.7 SOM Biotech SL
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Adrenoleukodystrophy Drugs Product Category, Application and Specification
    9.7.2.1 Product A
    9.7.2.2 Product B
  9.7.3 SOM Biotech SL Adrenoleukodystrophy Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.7.4 Main Business/Business Overview
9.8 Viking Therapeutics Inc
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Adrenoleukodystrophy Drugs Product Category, Application and Specification
    9.8.2.1 Product A
    9.8.2.2 Product B
  9.8.3 Viking Therapeutics Inc Adrenoleukodystrophy Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.8.4 Main Business/Business Overview

10 ADRENOLEUKODYSTROPHY DRUGS MAUFACTURING COST ANALYSIS

10.1 Adrenoleukodystrophy Drugs Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Adrenoleukodystrophy Drugs
10.3 Manufacturing Process Analysis of Adrenoleukodystrophy Drugs

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Adrenoleukodystrophy Drugs Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Adrenoleukodystrophy Drugs Major Manufacturers in 2016
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL ADRENOLEUKODYSTROPHY DRUGS MARKET FORECAST (2017-2022)

14.1 Global Adrenoleukodystrophy Drugs Sales Volume, Revenue and Price Forecast (2017-2022)
  14.1.1 Global Adrenoleukodystrophy Drugs Sales Volume and Growth Rate Forecast (2017-2022)
  14.1.2 Global Adrenoleukodystrophy Drugs Revenue and Growth Rate Forecast (2017-2022)
  14.1.3 Global Adrenoleukodystrophy Drugs Price and Trend Forecast (2017-2022)
14.2 Global Adrenoleukodystrophy Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  14.2.1 Global Adrenoleukodystrophy Drugs Sales Volume and Growth Rate Forecast by Regions (2017-2022)
  14.2.2 Global Adrenoleukodystrophy Drugs Revenue and Growth Rate Forecast by Regions (2017-2022)
  14.2.3 United States Adrenoleukodystrophy Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.4 China Adrenoleukodystrophy Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.5 Europe Adrenoleukodystrophy Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.6 Japan Adrenoleukodystrophy Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.7 Southeast Asia Adrenoleukodystrophy Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.8 India Adrenoleukodystrophy Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Adrenoleukodystrophy Drugs Sales Volume, Revenue and Price Forecast by Type (2017-2022)
  14.3.1 Global Adrenoleukodystrophy Drugs Sales Forecast by Type (2017-2022)
  14.3.2 Global Adrenoleukodystrophy Drugs Revenue Forecast by Type (2017-2022)
  14.3.3 Global Adrenoleukodystrophy Drugs Price Forecast by Type (2017-2022)
14.4 Global Adrenoleukodystrophy Drugs Sales Volume Forecast by Application (2017-2022)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology/Research Approach
  16.1.1 Research Programs/Design
  16.1.2 Market Size Estimation
  16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
  16.2.1 Secondary Sources
  16.2.2 Primary Sources
16.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Adrenoleukodystrophy Drugs
Figure Global Adrenoleukodystrophy Drugs Sales Volume Comparison (K Pcs) by Type (2012-2022)
Figure Global Adrenoleukodystrophy Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Biotin Product Picture
Figure DRX-065 Product Picture
Figure DUOC-01 Product Picture
Figure Lenti-D Product Picture
Figure MIN-102 Product Picture
Figure OP-101 Product Picture
Figure Others Product Picture
Figure Global Adrenoleukodystrophy Drugs Sales Comparison (K Pcs) by Application (2012-2022)
Figure Global Sales Market Share of Adrenoleukodystrophy Drugs by Application in 2016
Figure Children Examples
Table Key Downstream Customer in Children
Figure Adult Examples
Table Key Downstream Customer in Adult
Figure Global Adrenoleukodystrophy Drugs Market Size (Million USD) by Regions (2012-2022)
Figure United States Adrenoleukodystrophy Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Adrenoleukodystrophy Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Adrenoleukodystrophy Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Adrenoleukodystrophy Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Adrenoleukodystrophy Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Adrenoleukodystrophy Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Adrenoleukodystrophy Drugs Sales Volume (K Pcs) and Growth Rate (2012-2022)
Figure Global Adrenoleukodystrophy Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Market Major Players Adrenoleukodystrophy Drugs Sales Volume (K Pcs) (2012-2017)
Table Global Adrenoleukodystrophy Drugs Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table Global Adrenoleukodystrophy Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Adrenoleukodystrophy Drugs Sales Share by Players/Suppliers
Figure 2017 Adrenoleukodystrophy Drugs Sales Share by Players/Suppliers
Figure Global Adrenoleukodystrophy Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Adrenoleukodystrophy Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Adrenoleukodystrophy Drugs Revenue Share by Players/Suppliers (2012-2017)
Table 2016 Global Adrenoleukodystrophy Drugs Revenue Share by Players
Table 2017 Global Adrenoleukodystrophy Drugs Revenue Share by Players
Table Global Adrenoleukodystrophy Drugs Sales (K Pcs) and Market Share by Type (2012-2017)
Table Global Adrenoleukodystrophy Drugs Sales Share (K Pcs) by Type (2012-2017)
Figure Sales Market Share of Adrenoleukodystrophy Drugs by Type (2012-2017)
Figure Global Adrenoleukodystrophy Drugs Sales Growth Rate by Type (2012-2017)
Table Global Adrenoleukodystrophy Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table Global Adrenoleukodystrophy Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Adrenoleukodystrophy Drugs by Type (2012-2017)
Figure Global Adrenoleukodystrophy Drugs Revenue Growth Rate by Type (2012-2017)
Table Global Adrenoleukodystrophy Drugs Sales Volume (K Pcs) and Market Share by Region (2012-2017)
Table Global Adrenoleukodystrophy Drugs Sales Share by Region (2012-2017)
Figure Sales Market Share of Adrenoleukodystrophy Drugs by Region (2012-2017)
Figure Global Adrenoleukodystrophy Drugs Sales Growth Rate by Region in 2016
Table Global Adrenoleukodystrophy Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Adrenoleukodystrophy Drugs Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Adrenoleukodystrophy Drugs by Region (2012-2017)
Figure Global Adrenoleukodystrophy Drugs Revenue Growth Rate by Region in 2016
Table Global Adrenoleukodystrophy Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Adrenoleukodystrophy Drugs Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Adrenoleukodystrophy Drugs by Region (2012-2017)
Figure Global Adrenoleukodystrophy Drugs Revenue Market Share by Region in 2016
Table Global Adrenoleukodystrophy Drugs Sales Volume (K Pcs) and Market Share by Application (2012-2017)
Table Global Adrenoleukodystrophy Drugs Sales Share (%) by Application (2012-2017)
Figure Sales Market Share of Adrenoleukodystrophy Drugs by Application (2012-2017)
Figure Global Adrenoleukodystrophy Drugs Sales Market Share by Application (2012-2017)
Figure United States Adrenoleukodystrophy Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure United States Adrenoleukodystrophy Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure United States Adrenoleukodystrophy Drugs Sales Price (USD/Pcs) Trend (2012-2017)
Table United States Adrenoleukodystrophy Drugs Sales Volume (K Pcs) by Players (2012-2017)
Table United States Adrenoleukodystrophy Drugs Sales Volume Market Share by Players (2012-2017)
Figure United States Adrenoleukodystrophy Drugs Sales Volume Market Share by Players in 2016
Table United States Adrenoleukodystrophy Drugs Sales Volume (K Pcs) by Type (2012-2017)
Table United States Adrenoleukodystrophy Drugs Sales Volume Market Share by Type (2012-2017)
Figure United States Adrenoleukodystrophy Drugs Sales Volume Market Share by Type in 2016
Table United States Adrenoleukodystrophy Drugs Sales Volume (K Pcs) by Application (2012-2017)
Table United States Adrenoleukodystrophy Drugs Sales Volume Market Share by Application (2012-2017)
Figure United States Adrenoleukodystrophy Drugs Sales Volume Market Share by Application in 2016
Figure China Adrenoleukodystrophy Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure China Adrenoleukodystrophy Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Adrenoleukodystrophy Drugs Sales Price (USD/Pcs) Trend (2012-2017)
Table China Adrenoleukodystrophy Drugs Sales Volume (K Pcs) by Players (2012-2017)
Table China Adrenoleukodystrophy Drugs Sales Volume Market Share by Players (2012-2017)
Figure China Adrenoleukodystrophy Drugs Sales Volume Market Share by Players in 2016
Table China Adrenoleukodystrophy Drugs Sales Volume (K Pcs) by Type (2012-2017)
Table China Adrenoleukodystrophy Drugs Sales Volume Market Share by Type (2012-2017)
Figure China Adrenoleukodystrophy Drugs Sales Volume Market Share by Type in 2016
Table China Adrenoleukodystrophy Drugs Sales Volume (K Pcs) by Application (2012-2017)
Table China Adrenoleukodystrophy Drugs Sales Volume Market Share by Application (2012-2017)
Figure China Adrenoleukodystrophy Drugs Sales Volume Market Share by Application in 2016
Figure Europe Adrenoleukodystrophy Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Adrenoleukodystrophy Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Europe Adrenoleukodystrophy Drugs Sales Price (USD/Pcs) Trend (2012-2017)
Table Europe Adrenoleukodystrophy Drugs Sales Volume (K Pcs) by Players (2012-2017)
Table Europe Adrenoleukodystrophy Drugs Sales Volume Market Share by Players (2012-2017)
Figure Europe Adrenoleukodystrophy Drugs Sales Volume Market Share by Players in 2016
Table Europe Adrenoleukodystrophy Drugs Sales Volume (K Pcs) by Type (2012-2017)
Table Europe Adrenoleukodystrophy Drugs Sales Volume Market Share by Type (2012-2017)
Figure Europe Adrenoleukodystrophy Drugs Sales Volume Market Share by Type in 2016
Table Europe Adrenoleukodystrophy Drugs Sales Volume (K Pcs) by Application (2012-2017)
Table Europe Adrenoleukodystrophy Drugs Sales Volume Market Share by Application (2012-2017)
Figure Europe Adrenoleukodystrophy Drugs Sales Volume Market Share by Application in 2016
Figure Japan Adrenoleukodystrophy Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Japan Adrenoleukodystrophy Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Adrenoleukodystrophy Drugs Sales Price (USD/Pcs) Trend (2012-2017)
Table Japan Adrenoleukodystrophy Drugs Sales Volume (K Pcs) by Players (2012-2017)
Table Japan Adrenoleukodystrophy Drugs Sales Volume Market Share by Players (2012-2017)
Figure Japan Adrenoleukodystrophy Drugs Sales Volume Market Share by Players in 2016
Table Japan Adrenoleukodystrophy Drugs Sales Volume (K Pcs) by Type (2012-2017)
Table Japan Adrenoleukodystrophy Drugs Sales Volume Market Share by Type (2012-2017)
Figure Japan Adrenoleukodystrophy Drugs Sales Volume Market Share by Type in 2016
Table Japan Adrenoleukodystrophy Drugs Sales Volume (K Pcs) by Application (2012-2017)
Table Japan Adrenoleukodystrophy Drugs Sales Volume Market Share by Application (2012-2017)
Figure Japan Adrenoleukodystrophy Drugs Sales Volume Market Share by Application in 2016
Figure Southeast Asia Adrenoleukodystrophy Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Southeast Asia Adrenoleukodystrophy Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Adrenoleukodystrophy Drugs Sales Price (USD/Pcs) Trend (2012-2017)
Table Southeast Asia Adrenoleukodystrophy Drugs Sales Volume (K Pcs) by Players (2012-2017)
Table Southeast Asia Adrenoleukodystrophy Drugs Sales Volume Market Share by Players (2012-2017)
Figure Southeast Asia Adrenoleukodystrophy Drugs Sales Volume Market Share by Players in 2016
Table Southeast Asia Adrenoleukodystrophy Drugs Sales Volume (K Pcs) by Type (2012-2017)
Table Southeast Asia Adrenoleukodystrophy Drugs Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Adrenoleukodystrophy Drugs Sales Volume Market Share by Type in 2016
Table Southeast Asia Adrenoleukodystrophy Drugs Sales Volume (K Pcs) by Application (2012-2017)
Table Southeast Asia Adrenoleukodystrophy Drugs Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Adrenoleukodystrophy Drugs Sales Volume Market Share by Application in 2016
Figure India Adrenoleukodystrophy Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure India Adrenoleukodystrophy Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Adrenoleukodystrophy Drugs Sales Price (USD/Pcs) Trend (2012-2017)
Table India Adrenoleukodystrophy Drugs Sales Volume (K Pcs) by Players (2012-2017)
Table India Adrenoleukodystrophy Drugs Sales Volume Market Share by Players (2012-2017)
Figure India Adrenoleukodystrophy Drugs Sales Volume Market Share by Players in 2016
Table India Adrenoleukodystrophy Drugs Sales Volume (K Pcs) by Type (2012-2017)
Table India Adrenoleukodystrophy Drugs Sales Volume Market Share by Type (2012-2017)
Figure India Adrenoleukodystrophy Drugs Sales Volume Market Share by Type in 2016
Table India Adrenoleukodystrophy Drugs Sales Volume (K Pcs) by Application (2012-2017)
Table India Adrenoleukodystrophy Drugs Sales Volume Market Share by Application (2012-2017)
Figure India Adrenoleukodystrophy Drugs Sales Volume Market Share by Application in 2016
Table Applied Genetic Technologies Corp Basic Information List
Table Applied Genetic Technologies Corp Adrenoleukodystrophy Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Applied Genetic Technologies Corp Adrenoleukodystrophy Drugs Sales Growth Rate (2012-2017)
Figure Applied Genetic Technologies Corp Adrenoleukodystrophy Drugs Sales Global Market Share (2012-2017
Figure Applied Genetic Technologies Corp Adrenoleukodystrophy Drugs Revenue Global Market Share (2012-2017)
Table Bluebird Bio Inc Basic Information List
Table Bluebird Bio Inc Adrenoleukodystrophy Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bluebird Bio Inc Adrenoleukodystrophy Drugs Sales Growth Rate (2012-2017)
Figure Bluebird Bio Inc Adrenoleukodystrophy Drugs Sales Global Market Share (2012-2017
Figure Bluebird Bio Inc Adrenoleukodystrophy Drugs Revenue Global Market Share (2012-2017)
Table MedDay SA Basic Information List
Table MedDay SA Adrenoleukodystrophy Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure MedDay SA Adrenoleukodystrophy Drugs Sales Growth Rate (2012-2017)
Figure MedDay SA Adrenoleukodystrophy Drugs Sales Global Market Share (2012-2017
Figure MedDay SA Adrenoleukodystrophy Drugs Revenue Global Market Share (2012-2017)
Table Minoryx Therapeutics sl Basic Information List
Table Minoryx Therapeutics sl Adrenoleukodystrophy Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Minoryx Therapeutics sl Adrenoleukodystrophy Drugs Sales Growth Rate (2012-2017)
Figure Minoryx Therapeutics sl Adrenoleukodystrophy Drugs Sales Global Market Share (2012-2017
Figure Minoryx Therapeutics sl Adrenoleukodystrophy Drugs Revenue Global Market Share (2012-2017)
Table Pfizer Inc Basic Information List
Table Pfizer Inc Adrenoleukodystrophy Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer Inc Adrenoleukodystrophy Drugs Sales Growth Rate (2012-2017)
Figure Pfizer Inc Adrenoleukodystrophy Drugs Sales Global Market Share (2012-2017
Figure Pfizer Inc Adrenoleukodystrophy Drugs Revenue Global Market Share (2012-2017)
Table ReceptoPharm Inc Basic Information List
Table ReceptoPharm Inc Adrenoleukodystrophy Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure ReceptoPharm Inc Adrenoleukodystrophy Drugs Sales Growth Rate (2012-2017)
Figure ReceptoPharm Inc Adrenoleukodystrophy Drugs Sales Global Market Share (2012-2017
Figure ReceptoPharm Inc Adrenoleukodystrophy Drugs Revenue Global Market Share (2012-2017)
Table SOM Biotech SL Basic Information List
Table SOM Biotech SL Adrenoleukodystrophy Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure SOM Biotech SL Adrenoleukodystrophy Drugs Sales Growth Rate (2012-2017)
Figure SOM Biotech SL Adrenoleukodystrophy Drugs Sales Global Market Share (2012-2017
Figure SOM Biotech SL Adrenoleukodystrophy Drugs Revenue Global Market Share (2012-2017)
Table Viking Therapeutics Inc Basic Information List
Table Viking Therapeutics Inc Adrenoleukodystrophy Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Viking Therapeutics Inc Adrenoleukodystrophy Drugs Sales Growth Rate (2012-2017)
Figure Viking Therapeutics Inc Adrenoleukodystrophy Drugs Sales Global Market Share (2012-2017
Figure Viking Therapeutics Inc Adrenoleukodystrophy Drugs Revenue Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Adrenoleukodystrophy Drugs
Figure Manufacturing Process Analysis of Adrenoleukodystrophy Drugs
Figure Adrenoleukodystrophy Drugs Industrial Chain Analysis
Table Raw Materials Sources of Adrenoleukodystrophy Drugs Major Players in 2016
Table Major Buyers of Adrenoleukodystrophy Drugs
Table Distributors/Traders List
Figure Global Adrenoleukodystrophy Drugs Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Global Adrenoleukodystrophy Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Adrenoleukodystrophy Drugs Price (USD/Pcs) and Trend Forecast (2017-2022)
Table Global Adrenoleukodystrophy Drugs Sales Volume (K Pcs) Forecast by Regions (2017-2022)
Figure Global Adrenoleukodystrophy Drugs Sales Volume Market Share Forecast by Regions (2017-2022)
Figure Global Adrenoleukodystrophy Drugs Sales Volume Market Share Forecast by Regions in 2022
Table Global Adrenoleukodystrophy Drugs Revenue (Million USD) Forecast by Regions (2017-2022)
Figure Global Adrenoleukodystrophy Drugs Revenue Market Share Forecast by Regions (2017-2022)
Figure Global Adrenoleukodystrophy Drugs Revenue Market Share Forecast by Regions in 2022
Figure United States Adrenoleukodystrophy Drugs Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Adrenoleukodystrophy Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Adrenoleukodystrophy Drugs Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure China Adrenoleukodystrophy Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure Europe Adrenoleukodystrophy Drugs Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Europe Adrenoleukodystrophy Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Adrenoleukodystrophy Drugs Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Japan Adrenoleukodystrophy Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Adrenoleukodystrophy Drugs Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Adrenoleukodystrophy Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Adrenoleukodystrophy Drugs Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure India Adrenoleukodystrophy Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Global Adrenoleukodystrophy Drugs Sales (K Pcs) Forecast by Type (2017-2022)
Figure Global Adrenoleukodystrophy Drugs Sales Volume Market Share Forecast by Type (2017-2022)
Table Global Adrenoleukodystrophy Drugs Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Adrenoleukodystrophy Drugs Revenue Market Share Forecast by Type (2017-2022)
Table Global Adrenoleukodystrophy Drugs Price (USD/Pcs) Forecast by Type (2017-2022)
Table Global Adrenoleukodystrophy Drugs Sales (K Pcs) Forecast by Application (2017-2022)
Figure Global Adrenoleukodystrophy Drugs Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories